Characterization of human papillomavirus infection, P53 and ki-67 expression in cervix cancer of Mozambican women

被引:15
作者
Carrilho, C
Gouveia, P
Cantel, M
Alberto, M
Buane, L
David, L
机构
[1] Univ Porto, Inst Patol & Imunol Mol, P-4200 Oporto, Portugal
[2] Eduardo Mondlane Univ, Sch Med, Dept Pathol, Maputo, Mozambique
[3] Univ Porto, Fac Med, Oporto, Portugal
关键词
HPV; P53; Ki-67; cervix cancer; Mozambique;
D O I
10.1078/0344-0338-00422
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In this study, we aimed at evaluating the distribution of HPV types and the expression of P53 and Ki-67 in cervix carcinomas of Mozambican women. Fourty-seven invasive carcinomas, 10 CIN III, and 10 normal cervix were studied. P53 and Ki-67 expression was examined immunohistochemically. HPV infection and HPV types were detected by PCR (GP5+/bio-GP6+) and enzyme-immunoassay, respectively. Expression of P53 and Ki-67 and detection of HPV were as follows: normal cervix - 0%, 10%, and 0%, respectively; CIN III - 10%, 0%, and 100%, respectively; invasive carcinomas - 50%, 55.5%, and 70%, respectively. HPV 16 was identified in 54% of invasive carcinomas, HPV 31, 33, 35, and 45 in 23%, "unidentified" HPV in 19%, and HPV 18 in 4% of invasive carcinomas. No significant associations were observed between P53 expression, Ki-67 expression, and HPV infection. In conclusion, we observed a high frequency of HPV infection in CIN III lesions and invasive carcinomas from Mozambican women, with HPV 16 representing the most frequent viral type. HPV status was not related to P53 and Ki-67 expression. Both P53 and Ki-67 are associated with invasive cervix carcinomas, mainly of the squamous keratinizing histotype.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 51 条
[1]  
Abd El All H, 1999, Pathol Oncol Res, V5, P280, DOI 10.1053/paor.1999.0134
[2]   The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma [J].
AvallLundqvist, EH ;
Silfversward, C ;
Aspenblad, U ;
Nilsson, BR ;
Auer, GU .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (11) :1799-1804
[3]  
Bar J. K., 1996, European Journal of Gynaecological Oncology, V17, P378
[4]  
Bar JK, 2001, ANTICANCER RES, V21, P1001
[5]  
BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415
[6]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[7]   The causal relation between human papillomavirus and cervical cancer [J].
Bosch, FX ;
Lorincz, A ;
Muñoz, N ;
Meijer, CJLM ;
Shah, KV .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265
[8]  
Caruso ML, 1998, ANTICANCER RES, V18, P4097
[9]   Human papillomavirus genotypes in rural Mozambique [J].
Castellsagué, X ;
Menéndez, C ;
Loscertales, MP ;
Kornegay, JR ;
dos Santos, F ;
Gómez-Olivé, FX ;
Lloveras, B ;
Abarca, N ;
Vaz, N ;
Barreto, A ;
Bosch, FX ;
Alonso, P .
LANCET, 2001, 358 (9291) :1429-1430
[10]   Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix [J].
Chetty, R ;
Bramdev, A ;
AguirreArteta, A ;
Pegoraro, RJ ;
Sataar, N .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (05) :413-416